发明名称 PYRAZOLO COMPOUNDS AND USES THEREOF
摘要 Provided are compounds useful as inhibitors of one or more histone demethylases, such as KDM5. The invention also provides pharmaceutically acceptable compositions comprising compounds of the present invention and methods of using the present composition in the treatment of various disorders.
申请公布号 US2016060267(A1) 申请公布日期 2016.03.03
申请号 US201414775405 申请日期 2014.03.13
申请人 GENENTECH, INC. ;CONSTELLATION PHARMACEUTICALS, INC. 发明人 Albrecht Brian K.;Bellon Steven F.;Gehling Victor S.;Harmange Jean-Christophe;Lai Kwong Wah;Liang Jun;Dragovich Peter;Ortwine Dan;Labadie Sharada;Zhang Birong;Kiefer Jim
分类号 C07D487/04;A61K45/06;C12N9/99;A61K31/337;A61K31/517;A61K31/437;A61K31/519;A61K31/5377 主分类号 C07D487/04
代理机构 代理人
主权项 1. A compound of formula I:or a pharmaceutically acceptable salt thereof, wherein: R1 is —R, halogen, —OR, —SR, —N(R′)2, —CN, —NO2, —C(O)R, —CO2R, —C(O)N(R′)2, —C(O)SR, —C(O)C(O)R, —C(O)CH2C(O)R, —C(S)N(R′)2, —C(S)OR, —S(O)R, —SO2R, —SO2N(R′)2, —N(R′)C(O)R, —N(R′)C(O)N(R′)2, —N(R′)SO2R, —N(R′)SO2N(R′)2, —N(R′)N(R′)2, —N(R′)C(═N(R′))N(R′)2, —C═NN(R′)2, —C═NOR, —C(═N(R′))N(R′)2, —OC(O)R, or —OC(O)N(R′)2; each R is independently hydrogen or an optionally substituted group selected from C1-6 aliphatic, phenyl, a 3-7 membered saturated or partially unsaturated carbocyclic ring, an 8-10 membered bicyclic saturated, partially unsaturated or aryl ring, a 5-6 membered monocyclic heteroaryl ring having 1-3 heteroatoms independently selected from nitrogen, oxygen, or sulfur, a 4-7 membered saturated or partially unsaturated heterocyclic ring having 1-2 heteroatoms independently selected from nitrogen, oxygen, or sulfur, a 7-10 membered bicyclic saturated or partially unsaturated heterocyclic ring having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur, or an 8-10 membered bicyclic heteroaryl ring having 1-4 heteroatoms independently selected from nitrogen, oxygen, or sulfur; each R′ is independently —R, —C(O)R, —CO2R, or two R′ on the same nitrogen are taken together with their intervening atoms to form a 4-7 membered heterocyclic ring having 1-2 heteroatoms independently selected from nitrogen, oxygen, and sulfur; Ring A is R2 and R3 are independently —R, halogen, —OR, —SR, —N(R′)2, —CN, —NO2, —C(O)R, —CO2R, —C(O)N(R′)2, —C(O)SR, —C(O)C(O)R, —C(O)CH2C(O)R, —C(S)N(R′)2, —C(S)OR, —S(O)R, —SO2R, —SO2N(R′)2, —N(R′)C(O)R, —N(R′)C(O)N(R′)2, —N(R′)SO2R, —N(R′)SO2N(R′)2, —N(R′)N(R′)2, —N(R′)C(═N(R′))N(R′)2, —C═NN(R′)2, —C═NOR, —C(═N(R′))N(R′)2, —OC(O)R, or —OC(O)N(R′)2; or: R2 and R3 are taken together with their intervening atoms to form an optionally substituted 5-7 membered partially unsaturated or aromatic fused ring having 0-4 heteroatoms independently selected from nitrogen, oxygen, and sulfur; R2′ is —R, —OR, —SR, —N(R′)2, —C(O)R, —CO2R, —C(O)N(R′)2, —C(O)SR, —C(O)C(O)R, —C(O)CH2C(O)R, —C(S)N(R′)2, —C(S)OR, —S(O)R, —SO2R, —SO2N(R′)2, —N(R′)C(O)R, —N(R′)C(O)N(R′)2, —N(R′)SO2R, —N(R′)SO2N(R′)2, —N(R′)N(R′)2, —N(R′)C(═N(R′))N(R′)2, —C═NN(R′)2, —C═NOR, —C(═N(R′))N(R′)2, —OC(O)R, or —OC(O)N(R′)2; or: R2′ and R3 are taken together with their intervening atoms to form an optionally substituted 5-7 membered partially unsaturated or aromatic fused ring having 1-4 heteroatoms independently selected from nitrogen, oxygen, and sulfur; X is —N(R4)—, —O—, or —S—; R4 is —R, —C(O)R, —CO2R, or —S(O)2R; or: R4 and R3 are taken together with their intervening atoms to form an optionally substituted 5-7 membered saturated, partially unsaturated, or aromatic fused ring having 1-4 heteroatoms independently selected from nitrogen, oxygen, and sulfur; R5 is R, —C(O)R, —CO2R, —C(O)N(R′)2, —C(O)C(O)R, or —C(O)CH2C(O)R; or: R5 and R2 are taken together with their intervening atoms to form an optionally substituted 5-7 membered partially unsaturated or aromatic fused ring having 1-4 heteroatoms independently selected from nitrogen, oxygen, and sulfur; and R6 is —R, halogen, —OR, —SR, —N(R′)2, —CN, —NO2, —C(O)R, —CO2R, —C(O)N(R′)2, —C(O)SR, —C(O)C(O)R, —C(O)CH2C(O)R, —C(S)N(R′)2, —C(S)OR, —S(O)R, —SO2R, —SO2N(R′)2, —N(R′)C(O)R, —N(R′)C(O)N(R′)2, —N(R′)SO2R, —N(R′)SO2N(R′)2, —N(R′)N(R′)2, —N(R′)C(═N(R′))N(R′)2, —C═NN(R′)2, —C═NOR, —C(═N(R′))N(R′)2, —OC(O)R, or —OC(O)N(R′)2; or: R6 and R3 are taken together with their intervening atoms to form an optionally substituted 5-7 membered partially unsaturated or aromatic fused ring having 0-4 heteroatoms independently selected from nitrogen, oxygen, and sulfur;provided that the compound is other than any one of the following:and provided the compound is not a compound of formula (II):wherein: R1 is 3-(methylamino)propyl, when R2 is ethoxycarbonyl, and R3 is H; R1 is H, when R2 is H, and R3 is 2,3-dihydro-1,4-benzodioxin-6-yl; R1 is methoxy, when R2 is H, and R3 is 4-chlorophenyl; R1 is hydroxy, when R2 is H, and R3 is 4-chlorophenyl; R1 is H, when R2 is ethyl, ethoxycarbonylmethyl, 2-hydroxypropyl, 2-(acyloxy)propyl, 2-(acyloxy)ethyl, 2-(2-(N-benzyloxycarbonylamino)propanoyloxy)propyl, 2-chloropropyl, 1-(ethoxycarbonyl)ethyl, ethoxycarbonylmethyl, 1-(carboxy)ethyl, 1-(1-(methoxycarbonylethyl)ethoxycarbonyl)ethyl, 2-hydroxy-1-methylethyl, 2-hydroxyethyl, or 4-(trifluoromethylthio)benzyl, and R3 is methyl; R1 is H, when R2 is H, and R3 is phenyl, tetrahydropyran-4-ylmethyl, chloromethyl, methoxycarbonyl, ethoxycarbonylmethyl, benzyl, or 1-(2-fluorophenyl)cyclopropyl; R1 is H, when R2 is H, 4-benzyloxyphenyl, 3,4-dihydro-6,7-dimethyl-3-oxo-2-quinoxalinyl, or indol-3-yl, 3-pyrazolyl, ethoxycarbonyl, cyano, 3,4-dihydro-3-oxo-2-quinoxalinyl, or carboxy, and R3 is H; R1 is 3-aminopiperidino, when R2 is H, and R3 is trifluoromethyl; R1 is H, methyl, phenyl, N-(4-fluorophenyl)amino, N-phenylamino, N-benzylamino, N-(3,5-dimethoxyphenyl)amino, N-(3-methoxyphenyl)amino, N-(4-methoxyphenyl)amino, N-(3,4-dimethoxyphenyl)amino, N-(4-methylphenyl)amino N-(2-methoxyphenyl)amino, 4,5,6,7-tetrahydro-1H-indol-2-yl, N-(4-fluorophenyl)amino or N-(4-propylphenyl)amino, when R2 is H, and R3 is methyl; R1 is phenylamino, when R2 is H, and R3 is isopropyl; R1 is N-(3,5-dimethoxyphenyl)amino, when R2 is H, and R3 is phenyl, 2-fluorophenyl, 2-chlorophenyl, or chloromethyl; R1 is N-(3,5-dimethoxyphenyl)amino, when R2 is chloro, and R3 is methyl; R1 is methyl, N-(4-morpholinophenyl)amino, N-(3-methoxy-4-(2-morpholinoethoxy)phenyl)amino, N-(3,5-dimethoxyphenyl)amino, or N-(4-propylphenyl)amino, when R2 is H, and R3 is ethyl; R1 is N-(3-methoxy-5-(2-morpholinoethoxy)phenyl)amino, N-(3,5-dimethoxyphenyl)amino, phenylamino, N-(4-bromophenyl)amino, or N-(4-morpholinophenyl)amino, when R2 is H, and R3 is cyclopropyl; R1 is N-(3,5-dimethoxyphenyl)amino, when R2 is H, and R3 is isopropyl; R1 is N-(3,5-dimethoxyphenyl)amino, when R2 is methyl, and R3 is methyl; R1 is N-(3,5-dimethoxyphenyl)amino, when R2 is fluoro, and R3 is methyl; R1 is N-(3,5-dimethoxyphenyl)amino, when R2 is H, and R3 is methoxymethyl; R1 is N-(3,5-dimethoxyphenyl)amino, when R2 is H, and R3 is methoxycarbonylmethyl; R1 is H, methyl or N-(3,5-dimethoxyphenyl)amino, when R2 is H, and R3 is propyl; R1 is H, methyl or N-(3,5-dimethoxyphenyl)amino, when R2 is benzyl, and R3 is methyl; R1 is H or methyl, when R2 is benzyl, and R3 is H; R1 is N-(3,5-dimethoxyphenyl)amino, when R2 is H, and R3 is phenyl, 2-pyridyl, or N,N-dimethylaminomethyl; R1 is H, when R2 is 2-hydroxyethyl, 2-chloroethyl, 2-(acyloxy)ethyl, and R3 is ethoxycarbonyl; R1 is H, when R2 is 2-hydroxyethyl, and R3 is hydroxy; R1 is H, when R2 is 2-(acyloxy)ethyl, and R3 is benzyloxymethyl; R1 is 2-pyrrolyl, when R2 is H, and R3 is H; R1 is N-(4-ethoxyphenyl)amino, when R2 is 3,4-dihydro-6,7-dimethyl-3-oxo-2-quinoxalinyl, and R3 is H; R1 is H, when R2 is 2-(acyloxy)ethyl, and R3 is methoxymethyl; R1 is H, when R2 is cyano, and R3 is phenyl or 4-chlorophenyl; R1 is methyl, when R2 is 3,4-dihydro-3-oxo-2-quinoxalinyl, and R3 is H; R1 is H, when R2 and R3 taken together form a fused benzo ring; R1 is H, when R2 is 3-methoxybenzyl, and R3 is propyl; R1 is methyl, when R2 is H, ethyl, ethoxycarbonylmethyl, or 3-chlorobenzyl, and R3 is methyl; R1 is pyrrolidino, when R2 is H, and R3 is 3-chlorobenzyl, 5-(propyl)isoxazol-3-yl, or 4-nitrophenyl; R1 is morpholino, when R2 is H, and R3 is tetrahydropyran-2-yl; R1 is pyrrolidino, when R2 is benzoylamino, and R3 is H; R1 is N-(4-methoxyphenyl)amino, when R2 is H, and R3 is 4-nitrophenyl; R1 is H, when R2 is 2-(2,4-dichlorobenzoyloxy)ethyl, 2-(3-methylbenzoyloxy)ethyl, 2-(acetoxy)ethyl or 2-(cyclohexylcarbonyloxy)ethyl, and R3 is methyl; R1 is methyl, when R2 and R3 taken together form a fused cyclopentyl ring; R1 is H, when R2 and R3 taken together form a fused cyclohexyl ring; R1 is methyl, when R2 is H, and R3 is ethoxycarbonylmethyl; R1 is phenyl, when R2 is H, and R3 is methyl or amino; R1 is H, when R2 is chloro, and R3 is methyl; R1 is methyl, R2 is H, and R3 is phenyl; R1 is methyl, R2 is 2-hydroxyethyl, and R3 is methyl; or R1 is methylthio, R2 is H, and R3 is phenyl; andprovided that the compound is other than any one of the following:
地址 South San Francisco CA US